NL-OMON29769已完成不适用
ong-term follow-up and prognosis of patients with ulnar neuropathy at the elbow in which the electrodiagnostic study shows a motor conduction block of more than 50% - prognosis of ulnar neuropathy with an severe motor conduction block
Sint Elisabeth Ziekenhuis0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Every patient with proven ulnar neuropathy at the elbow with at electrodiagnostic testing a motor conduction block of the abductor digiti minimi (ADM) and the musculus interosseus I (MII) of >= 50%.
- •Informed consent
排除标准
- •* Acute trauma origin of the ulnar neuropathy
- •* History of a polyneuropathy
- •* Findings of polyneuropathy during physical examination.
- •* Genetically proven hereditary neuropathy with liability to pressure palsies
- •* Alcohol-abuse, chemotherapy
研究者
相似试验
尚未招募
2 期
Short and long-term outcome of patients undergoing pancreaticoduodenectomy - a single institute prospective cohort studyPeri-ampullar tumorJPRN-UMIN000052755Kobe City Medical Center General Hospital40
进行中（未招募）
1 期
A long-term follow-up study for patients treated with Galapagos CAR T cell therapiesRelapsed/refractory B-Cell non-Hodgkin lymphoma, Relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Relapsed/refractory multiple myelomaMedDRA version: 21.0Level: LLTClassification code: 10051812Term: Small cell lymphocytic lymphoma Class: 10029104MedDRA version: 20.0Level: HLGTClassification code: 10025320Term: Lymphomas non-Hodgkin's B-cell Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104CTIS2023-510173-34-00Galapagos300
尚未招募
不适用
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in a prior clinical study.Renal transplant rejectionAllograft rejection1002766510029149NL-OMON56013Sangamo Therapeutics France SAS8
进行中（未招募）
1 期
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg therapy, TX200-TR101) in a prior clinical study.Prevention of immune mediated allograft rejection in patients with end-stage renal disease (ESRD) who are tissue typed as HLA-A*02 negative and have received a kidney transplant from an HLA-A*02 positive living donor.MedDRA version: 21.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2022-002440-40-DESangamo Therapeutics France SAS15
进行中（未招募）
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200